ABBV
AbbVie Inc.
Stock
$266.28+1.94 (+0.73%)Close Sep 28, 2026
ABBV's free cash flow for 2025 was $17.82 billion, down 0.1% from the year before.
From SEC filings, Latest filing: 10-Q, Aug 3, 2026
| Free cash flow (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $18.21B | −0.2% | 1.2% | 9.8% |
| Free cash flow (TTM) | $18.21B |
|---|---|
| YoY | −0.2% |
| 5-year CAGR | 1.2% |
| 10-year CAGR | 9.8% |
Free cash flow
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $17.8B | −0.1% |
| 2024 | $17.8B | −19.2% |
| 2023 | $22.1B | −9.0% |
| 2022 | $24.2B | +10.3% |
| 2021 | $22.0B | +31.0% |
| 2020 | $16.8B | +31.5% |
| 2019 | $12.8B | −0.1% |
| 2018 | $12.8B | +35.6% |
| 2017 | $9.4B | +43.7% |
| 2016 | $6.6B | −6.3% |
| 2015 | $7.0B | +138.4% |
| 2014 | $2.9B | −49.2% |
| 2013 | $5.8B | −3.9% |
| 2012 | $6.0B | +2.1% |
| 2011 | $5.9B | — |